The rtx1 Adaptive Optics Retinal Camera * is the first device that enables researchers to visualize the retina at the cellular level, thereby complementing their current imaging technologies including Optical Coherence Tomography (OCT) and Scanning Laser Ophthalmoscopy (SLO).

Although OCT and SLO have both revolutionized research into retinal diseases including glaucoma, age-related macular degeneration (AMD), diabetic retinopathy and other, rarer, inherited pathologies, they lack the resolution to visualize the retina’s microstructures.  This limitation is due to the natural optical defects, or aberrations, present in every eye to varying degrees.  Because most retinal diseases manifest themselves at the cellular level, research, especially into early detection, is hindered as potential subjects almost always come forward once they have already suffered considerable vision loss.

The rtx1 is the first technology suitable for use in research environments that employs adaptive optics to compensate for the eye’s aberrations in order to provide in vivo cellular-level images of the retina.  Studies are currently underway to determine how adaptive-optics retinal imaging may one day enter into the diagnostic and patient care chain.

Click here to see preliminary rtx1 specifications.

To be kept informed of news, publications and other advances, click here.

To view images acquired using the rtx1, click here.

For more information or, if you are interested in becoming an investigational partner site, please contact Laurent Vabre via e-mail by clicking here or by telephone on +33 (0)1 64 86 15 66.

* Research use only (R.U.O).  Not for sale as a diagnostic device.